Skip to main content Back to Top
Advertisement

7/10/2020

Loxapine Tablets

Products Affected - Description

    • Loxapine oral tablet, Lannett, 10 mg, bottle, tablet 100 count, NDC 00527-1395-01
    • Loxapine oral tablet, Lannett, 25 mg, bottle, tablet 100 count, NDC 00527-1396-01
    • Loxapine oral tablet, Lannett, 5 mg, bottle, tablet 100 count, NDC 00527-1394-01
    • Loxapine oral tablet, Lannett, 50 mg, bottle, tablet 100 count, NDC 00527-1397-01
    • Loxapine oral tablet, Mylan Institutional, 10 mg, bottle, tablet 100 count, NDC 00378-7010-01
    • Loxapine oral tablet, Mylan Institutional, 25 mg, bottle, tablet 100 count, NDC 00378-7025-01
    • Loxapine oral tablet, Mylan Institutional, 5 mg, bottle, tablet 100 count, NDC 00378-7005-01
    • Loxapine oral tablet, Mylan Institutional, 50 mg, bottle, tablet 100 count, NDC 00378-7050-01
    • Loxapine oral tablet, Teva, 10 mg, bottle, tablet 100 count, NDC 00591-0370-01
    • Loxapine oral tablet, Teva, 25 mg, bottle, tablet 100 count, NDC 00591-0371-01
    • Loxapine oral tablet, Teva, 5 mg, bottle, tablet 100 count, NDC 00591-0369-01
    • Loxapine oral tablet, Teva, 50 mg, bottle, tablet 100 count, NDC 00591-0372-01

Reason for the Shortage

    • Teva did not provide a reason for the shortage.
    • Marlex has loxapine tablets available.
    • Lannett did not provide a reason for the shortage.
    • Mylan Institutional did not provide a reason for the shortage.

Available Products

    • Loxapine oral tablet, Marlex, 10 mg, bottle, tablet 100 count, NDC 10135-0586-01
    • Loxapine oral tablet, Marlex, 25 mg, bottle, tablet 100 count, NDC 10135-0587-01
    • Loxapine oral tablet, Marlex, 5 mg, bottle, tablet 100 count, NDC 10135-0585-01
    • Loxapine oral tablet, Marlex, 50 mg, bottle, tablet 100 count, NDC 10135-0588-01

Estimated Resupply Dates

    • Lannett has loxapine 5 mg, 10 mg, 25, mg and 50 mg tablets on back order and the company estimates a release date in early-August 2020.
    • Mylan Institutional has loxapine 5 mg, 10 mg, 25 mg, and 50 mg tablets on back order and the company cannot estimate a release date.
    • Teva has loxapine 5 mg, 25 mg, and 50 mg tablets on back order and the company estimates release dates in late-August 2020. The 10 mg tablets are on back order and the company cannot estimate a release date.

Updated

Updated July 10, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 12, 2019 by Rachael Freeman, PharmD, BCPS. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.